What wavelength should be used for phototherapy in neonatal jaundice, dermatologic conditions (psoriasis, vitiligo, atopic dermatitis), and PUVA therapy?

Phototherapy Wavelength Recommendations

For neonatal jaundice, use narrow-band blue-to-green LED phototherapy at 460-490 nm wavelength range, with 478 nm being optimal, delivered at an irradiance of at least 30 μW/cm²/nm. 1

Neonatal Hyperbilirubinemia

The 2024 American Academy of Pediatrics guideline provides the most definitive evidence for neonatal phototherapy wavelengths. The optimal therapeutic window is 460-490 nm (blue-green spectrum), with peak efficacy at 478 nm 1. This wavelength range maximally overlaps with the bilirubin absorption spectrum, enabling efficient photo-isomerization of unconjugated bilirubin to water-soluble excretable forms.

Key Technical Requirements:

• Wavelength: 460-490 nm (478 nm optimal)
• Irradiance: Minimum 30 μW/cm²/nm for term infants (25-35 μW/cm²/nm range acceptable)
• Body surface area exposure: 35-80% of infant's body
• Light source: Narrow-band blue-green LED lamps preferred over fluorescent, halogen, or fiberoptic sources 1

The mechanism involves rapid photo-isomerization occurring within the skin microcirculation, with peak conversion at 120 minutes. Approximately 75% converts to the 4E,15Z photoisomer, 20% to 4Z,15E photoisomer, and 5% to lumirubin 1. Bilirubin levels should decrease within 4-6 hours of initiating effective phototherapy 1.

Critical Pitfall:

Green light (530 nm) is not only ineffective but can actually reverse the photoisomerization reaction 2. Ensure phototherapy devices exclude green wavelengths from their emission spectrum.

Dermatologic Conditions

Psoriasis, Atopic Dermatitis, and General Inflammatory Conditions

Narrowband UVB at 311-313 nm is the first-line phototherapy choice for pediatric and adult psoriasis, atopic dermatitis, and most inflammatory dermatoses 3, 4, 5. This has largely replaced broadband UVB (290-320 nm) due to superior efficacy and safety profile.

The 2010 AAD guideline establishes narrowband UVB as preferred over PUVA therapy for initial treatment because it:

• Requires no systemic medication
• Avoids 24-hour protective eyewear requirements
• Produces less erythema
• Has easier delivery logistics 3

Alternative wavelengths by indication:

• Excimer laser (308 nm): For localized psoriasis, vitiligo, and alopecia areata 4, 6
• UVA1 (340-400 nm): For conditions with deeper dermal infiltration including morphea and mastocytosis 4
• Broadband UVB (290-320 nm): Historical option, now superseded by narrowband UVB 3

Vitiligo

Narrowband UVB (311-313 nm) is the phototherapy standard for vitiligo 4, 6. The excimer laser at 308 nm provides an alternative for localized disease, allowing targeted treatment of specific patches 4.

The mechanism involves stimulation of melanogenesis and melanocyte proliferation. For recalcitrant cases, combination with topical therapies (ruxolitinib, roflumilast) may enhance repigmentation 7.

PUVA Therapy (Psoralen + UVA)

PUVA uses UVA wavelengths (320-400 nm) activated by psoralen photosensitizers 3, 5. While effective for severe psoriasis, cutaneous T-cell lymphomas, and some cases of vitiligo, it has been relegated to second-line therapy due to:

• Requirement for systemic or topical psoralen administration
• Mandatory 24-hour UV-protective eyewear
• Higher erythema risk
• More complex administration 3, 4

PUVA remains indicated for:

• Severe recalcitrant psoriasis unresponsive to narrowband UVB
• Cutaneous T-cell lymphomas (including extracorporeal photopheresis)
• Conditions requiring deeper dermal penetration 3, 5

Mechanism Considerations

The wavelength determines depth of penetration and therapeutic target:

• UVB (290-320 nm): Primarily affects epidermis and superficial dermis; absorbed by DNA, causing immunosuppression and cell cycle arrest 5
• Narrowband UVB (311-313 nm): Optimized epidermal/superficial dermal effects with reduced erythema 3
• UVA (320-400 nm): Penetrates to mid and deep dermis, affects blood vessels and deeper structures 5

Monitoring and Safety

For neonatal phototherapy, use irradiance meters calibrated specifically for the wavelength range of your device 1. Generic meters may provide inaccurate readings across different light sources.

For dermatologic phototherapy in children, parental partnership is essential for compliance—parents should assist with maintaining protective eyewear and preventing movement during treatment 4.